What is Nephros's market cap?

Nephros (NEPH) has a market capitalization of $37.2M and trades on NASDAQ.

Who are Nephros's competitors?

Nephros's key competitors include Pentair, Cytiva, 3M Company, and others. These companies compete in similar markets and product categories.

Who does Nephros partner with?

Nephros's notable partners include Medica S.p.A., Donastar LLC.

Where is Nephros headquartered?

Nephros is headquartered in United States of America and employs approximately 31 people. It has been publicly traded since 2004.

Nephros

NEPH

Nephros is a commercial-stage medical technology company that develops and markets high-performance water filtration solutions designed to prevent infection and ensure water purity.

Market cap

$37.24M-0.5%

Table of contents

Earnings

Q1 2026 report

May 7, 2026

Revenue$5.2MBeat by $194.0K EPS$0.01In line

Read the full report

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$5.0M

EPS estimate$0.01

Competitors

By market cap

UFP Technologies$1.9B+2.0%

Nephros$37.2M-2.4%

Aethlon Medical$1.5M-42.4%

Nuwellis, Inc.$183.5K-90.2%

By revenue growth

Repligen+22.3%

UFP Technologies+11.2%

Danaher+4.6%

3M+2.4%

Pentair-2.2%

By net margin

UFP Technologies11.27%-0.3pp

Profile

Nephros is a commercial-stage medical technology company that develops and markets high-performance water filtration solutions designed to prevent infection and ensure water purity. The company specializes in medical-grade ultrafiltration and microfiltration technologies that physically remove bacteria, viruses, and endotoxins from water systems. Its core value proposition centers on providing FDA 510(k)-cleared solutions for critical-use environments where water quality is essential to patient safety and operational compliance.

Competitive position

Nephros distinguishes itself through FDA 510(k)-cleared medical-grade validation and superior membrane surface area that offers longer service life than many competitors.

GeographiesUnited States, Canada, Brazil, Italy

Customer segmentsHealthcare Providers, Foodservice and Hospitality, Government and Federal Facilities, Industrial and Manufacturing

Business modelManufacturing, Direct Sales, Distributor-led sales

SuppliersPolysulfone hollow fiber membrane suppliers, Contract medical device manufacturers, Specialized raw material providers

CustomersHospital procurement departments, Dialysis center operators, Foodservice franchise owners, Facility managers

CountryUnited States of America

Listed2004

Employees31.0

CEORobert Banks

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websitenephros.com

FilingsSEC EDGAR

Questions, answered.

What is Nephros's market cap?: Nephros (NEPH) has a market capitalization of $37.2M and trades on NASDAQ.
Who are Nephros's competitors?: Nephros's key competitors include Pentair, Cytiva, 3M Company, and others. These companies compete in similar markets and product categories.
Who does Nephros partner with?: Nephros's notable partners include Medica S.p.A., Donastar LLC.
Where is Nephros headquartered?: Nephros is headquartered in United States of America and employs approximately 31 people. It has been publicly traded since 2004.